NEXT BIOMETRICS GROUP AS (NEXT.OL) Stock Balance Sheet
OSL:NEXT - Euronext Oslo - NO0010629108 - Common Stock - Currency: NOK
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 62.91M | 67.75M | 69.30M | 102.71M | 67.95M | |||
| Receivables | 62.81M | 17.19M | 12.59M | 11.80M | 4.06M | |||
| Inventories | 17.67M | 23.13M | 22.93M | 18.99M | 21.73M | |||
| Other Current Assets | 6.94M | 2.56M | 2.06M | 7.70M | 14.34M | |||
| Total Current Assets | 150.33M | 110.63M | 106.89M | 141.19M | 108.07M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.09M | 6.74M | 12.35M | 16.45M | 17.20M | |||
| Intangibles | 825.00K | 1.53M | 2.58M | 3.98M | 5.45M | |||
| Other Non-Current Assets | 3.00K | 0.00 | 38.00K | 32.00K | 762.00K | |||
| Total Non-Current Assets | 7.92M | 8.27M | 14.96M | 20.46M | 23.41M | |||
| TOTAL ASSETS | 158.25M | 118.90M | 121.85M | 161.66M | 131.48M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.84M | 1.75M | 1.75M | 2.60M | 4.44M | |||
| Accrued Expenses | N/A | 8.09M | 3.41M | 6.98M | 3.89M | |||
| Accounts Payable | 10.91M | 5.98M | 7.78M | 6.79M | 11.05M | |||
| Other Current Liabilities | 18.34M | 8.54M | 11.64M | 9.01M | 8.01M | |||
| Total Current Liabilities | 31.09M | 24.36M | 24.57M | 25.38M | 27.38M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.24M | 194.00K | 1.22M | 0.00 | 5.61M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 0.00 | 135.00K | |||
| Other Non-Current Liabilities | N/A | 0.00 | 61.00K | 2.03M | 1.16M | |||
| Total Non-Current Liabilities | 2.24M | 194.00K | 1.28M | 2.03M | 6.91M | |||
| TOTAL LIABILITIES | 33.33M | 24.55M | 25.85M | 27.40M | 34.29M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -70.09M | -40.53M | -30.00K | -4.76M | -35.39M | |||
| Additional Paid In Capital | 79.86M | 30.86M | 4.05M | 47.34M | 56.63M | |||
| Common Shares | 115.16M | 104.03M | 91.98M | 91.68M | 75.94M | |||
| Other Shareholders' Equity | 1.00K | 1.00K | N/A | N/A | 1.00K | |||
| Shares Outstanding | 115.15M | 104.02M | 91.98M | 75.94M | 75.94M | |||
| Tangible Book Value per Share | 1.08 | 0.89 | 1.02 | 1.72 | 1.21 | |||
| Total Shareholders' Equity | 124.92M | 94.35M | 96.00M | 134.25M | 97.19M | |||
| TOTAL LIABILITIES AND EQUITY | 158.25M | 118.90M | 121.85M | 161.66M | 131.48M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.00 | 0.01 | N/A | 0.06 | |||
| Current Ratio | 4.84 | 4.54 | 4.35 | 5.56 | 3.95 | |||
| Return On Assets (ROA) | -24.68% | -55.28% | -38.02% | -37.12% | -77.42% | |||
| Return On Equity (ROE) | -31.26% | -69.67% | -48.26% | -44.70% | -104.74% | |||
All data in NOK , ROIC based on taxRate of 0.23